Altering The Transition From Acute to Chronic Pain (ATTAC-Pain)

NCT03315533 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Musculoskeletal Pain

Interventions

DRUG: Duloxetine 30 milligrams (MG)
DRUG: Duloxetine 60 milligrams (MG)
DRUG: Placebo Oral Tablet

Sponsor

Rhode Island Hospital

Collaborators

[object Object]
[object Object]